| Increasing access to hepatitis C virus medications: a program model using patient navigators and specialty pharmacy to obtain prior authorization approval TM Vu, W Toribio, F Riazi, G Ciprian, N Gibbs, M Giardina, JA Camacho, ... Journal of managed care & specialty pharmacy 24 (4), 329-333, 2018 | 33 | 2018 |
| Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City J Ziff, T Vu, D Dvir, F Riazi, W Toribio, S Oster, K Sigel, J Weiss Harm Reduction Journal 18, 1-8, 2021 | 12 | 2021 |
| Transitioning clinical care for people who use drugs to telemedicine: Lessons learned one year into the COVID-19 pandemic K Dunham, M Giardina, B Kolod, E McBratney, P Medina Blanco, F Riazi, ... Telemedicine and e-Health 27 (8), 929-933, 2021 | 9 | 2021 |
| Community case study of naloxone distribution by hospital-based harm reduction program for people who use drugs in New York City F Riazi, W Toribio, E Irani, TM Hughes, Z Huxley-Reicher, E McBratney, ... Frontiers in Sociology 6, 619683, 2021 | 7 | 2021 |
| Primary care based model using patient navigators highly successful in obtaining HCV medications for inner-city HCV-monoinfected patients W Toribio, F Riazi, GC Ciprian, N Gibbs, M Giardina, JA Camacho, ... HEPATOLOGY 64, 992A-993A, 2016 | | 2016 |
